IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q1 2023 Holdings

Filed 2023-05-09 | 16 holdings | $207.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$100.6M6,068,12548.4%
Biomea Fusion Inc. (Bmea)(BMEA)COM09077A106$24.8M798,75711.9%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$22.4M1,115,35210.8%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$21.6M1,025,00010.4%
Monte Rosa Therapeutics Inc. (Glue)(GLUE)COM61225M102$11.5M1,472,3315.5%
Elevation Oncology Inc. (Elev)COM28623U101$5.4M2,834,9102.6%
Reneo Pharmaceuticals Inc. (Rphm)(RPHM)COM75974E103$5.3M886,0752.5%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$4.2M2,541,0092.0%
Aclaris Theraputics Inc. (Acrs)(ACRS)COM00461U105$3.5M434,4551.7%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$3.2M1,043,2671.5%
Spruce Biosciences, Inc. (Sprb)COM85209E109$2.7M1,205,5111.3%
Avrobio, Inc. (Avro)COM05455M100$1.0M1,009,7790.5%
Aeglea Biotherapeutics Inc. (Agle)(AGLEUSD)COM00773J103$490.4K1,691,1510.2%
Viracta Therapeutics Inc. (Virx)COM92765F108$458.8K288,5710.2%
Atreca Inc. (Bcel)(BCELUSD)CL A COM04965G109$441.9K387,6530.2%
Marker Therapeutics, Inc. (Mrkr)COM57055L107$223.1K314,2860.1%